Paper17544165
Lipid nanoparticles for improved topical application of drugs for skin diseases.
Schäfer-Korting M and 2 others. Adv Drug Deliv Rev, 2007. Cited by 368 papers, by iCite.
Cite this record
ConductScience Library. Lipid nanoparticles for improved topical application of drugs for skin diseases. Papers, record 17544165. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17544165
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Carriers | Major topic |
| Nanoparticles | Major topic |
| Skin Diseases | Major topic |
| Administration, Topical | |
| Animals | |
| Humans | |
| Lipids | |
| Pharmaceutical Preparations | |
| Skin Absorption |
Source PubMed
Cited by118
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 368 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42840803 | Lipid matrix composition-tuned nanoparticles for enhanced topical retinol delivery and anti-photoaging efficacy. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42840803 | PubMed |
| 42755299 | Lipid-Based Nanocarriers for Intranasal Delivery: Revolutionizing Neurological Disorder Therapies. | Curr Top Med Chem | 2026 | https://conductscience.org/library/papers/42755299 | PubMed |
| 42514932 | In Vitro and Ex Vivo Studies on the Absorption and Distribution of β-Cyclodextrin Polymer. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514932 | PubMed |
| 42220974 | Lipid-Based Nanocarriers for Curcumin Delivery: A Promising Strategy in The Management of Inflammatory Diseases. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42220974 | PubMed |
| 42076079 | Advances in Nanotechnology-Assisted Delivery of TCM-Derived Bioactive Compounds for Wound Repair. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42076079 | PubMed |
| 41599167 | Quality by Design for the Nanoformulation of Cosmeceuticals. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41599167 | PubMed |
| 41079789 | Validation of breast cancer as a risk factor for anxiety and depression: Insights from Mendelian randomization analysis. | J Pharm Anal | 2025 | https://conductscience.org/library/papers/41079789 | PubMed |
| 40299379 | Novel Small-Molecule Treatment and Emerging Biological Therapy for Psoriasis. | Biomedicines | 2025 | https://conductscience.org/library/papers/40299379 | PubMed |
| 40277615 | Smart Nanocarriers in Cosmeceuticals Through Advanced Delivery Systems. | Biomimetics (Basel) | 2025 | https://conductscience.org/library/papers/40277615 | PubMed |
| 39830167 | Metabolomic profiling and antibacterial efficacy of probiotic-derived cell-free supernatant encapsulated in nanostructured lipid carriers against canine multidrug-resistant bacteria. | Front Vet Sci | 2024 | https://conductscience.org/library/papers/39830167 | PubMed |
| 39403134 | Hyaluronic acid-solid lipid nano transporter serum preparation for enhancing topical tretinoin delivery: skin safety study and visual assessment of skin. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39403134 | PubMed |
| 39400025 | Optimization, Formulation, and Ex vivo Evaluation of Solid Lipid Nanoparticles for Transdermal Delivery of Diltiazem Hydrochloride. | Pharm Nanotechnol | 2026 | https://conductscience.org/library/papers/39400025 | PubMed |
| 39384727 | New Insight for Enhanced Topical Targeting of Caffeine for Effective Cellulite Treatment: In Vitro Characterization, Permeation Studies, and Histological Evaluation in Rats. | AAPS PharmSciTech | 2024 | https://conductscience.org/library/papers/39384727 | PubMed |
| 39082164 | Topical Administration of Nanostructured Lipid Carriers as a Viable Approach to Reduce Inflammation: A Review. | Antiinflamm Antiallergy Agents Med Chem | 2025 | https://conductscience.org/library/papers/39082164 | PubMed |
| 39022452 | Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications. | J Lipids | 2024 | https://conductscience.org/library/papers/39022452 | PubMed |
| 38675215 | Microemulsions and Nanoemulsions for Topical Delivery of Tripeptide-3: From Design of Experiment to Anti-Sebum Efficacy on Facial Skin. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38675215 | PubMed |
| 38675110 | Recent Approaches for the Topical Treatment of Psoriasis Using Nanoparticles. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38675110 | PubMed |
| 38639280 | Nanogels as Drug Delivery Carrier: A Narrative Review on Formulation Techniques, Characterization, Applications and Patents. | Curr Pharm Biotechnol | 2025 | https://conductscience.org/library/papers/38639280 | PubMed |
| 38585452 | Green Formulation of Spironolactone Loaded Chitosan-Coated Nano Lipid Carrier for Treatment of Acne Vulgaris: A Randomized Double-Blind Clinical Trial. | Adv Pharm Bull | 2024 | https://conductscience.org/library/papers/38585452 | PubMed |
| 38435752 | Development of Curcumin and Turmerone Loaded Solid Lipid Nanoparticle for Topical Delivery: Optimization, Characterization and Skin Irritation Evaluation with 3D Tissue Model. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/38435752 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17544165
GET https://conductscience.org/api/papers/v1/17544165/cited_by?page=2